150840 — IntroMedic Co Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for IntroMedic Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS/A | Annual Audited Accounts | Annual Audited Accounts | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 8,836 | 5,963 | 7,871 | 9,878 | 10,158 |
| Cost of Revenue | |||||
| Gross Profit | 5,613 | 3,167 | 4,577 | 6,636 | 6,375 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 19,096 | 10,926 | 12,539 | 15,259 | 16,880 |
| Operating Profit | -10,260 | -4,963 | -4,668 | -5,381 | -6,722 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19,319 | -7,349 | -13,854 | -23,315 | -6,857 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -19,320 | -7,375 | -13,860 | -23,336 | -6,865 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -18,937 | -7,224 | -13,742 | -23,265 | -6,817 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -18,937 | -7,224 | -13,742 | -23,265 | -6,817 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -740 | -263 | -399 | -597 | -168 |
| Dividends per Share |